Evidence map›Paper›PMID 37232845›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study.

Joseph D Phillips, Kayla A Fay, Alan J Bergeron, Peisheng Zhang, Daniel W Mielcarz, Andrew M Calkins, Tyler G Searles, Brock C Christensen, David J Finley, Mary Jo Turk and 1 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joseph D PhillipsDepartment of Surgery, Dartmouth-Hitchcock Medical Center, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Kayla A FayDepartment of Surgery, Dartmouth-Hitchcock Medical Center, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Alan J BergeronDartLab, Dartmouth Cancer Center, Lebanon, NH 03756, USA.
Peisheng ZhangDartLab, Dartmouth Cancer Center, Lebanon, NH 03756, USA.
Daniel W MielcarzDartLab, Dartmouth Cancer Center, Lebanon, NH 03756, USA.ORCID 0000-0001-8784-8386
Andrew M CalkinsDartLab, Dartmouth Cancer Center, Lebanon, NH 03756, USA.
Tyler G SearlesDepartment of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Brock C ChristensenDepartments of Epidemiology and Molecular & Systems Biology, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
David J FinleyDepartment of Surgery, Dartmouth-Hitchcock Medical Center, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Mary Jo TurkDepartment of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Jacqueline Y ChannonDartLab, Dartmouth Cancer Center, Lebanon, NH 03756, USA.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
SYNERGY: The Dartmouth Center for clinical and Translational ScienceUL1TR001086 · NCATS · DARTMOUTH COLLEGE · PI GREEN, ALAN I · 2013 to 2017
$18.3M
Tissue Resident memory T cell responses to cancerR01CA225028 · NCI · DARTMOUTH COLLEGE · PI Mary Jo Turk · 2018 to 2026
$4.9M
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomesR01CA216265 · NCI · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2017 to 2021
$2.9M
Sustaining Tissue Resident Memory T cellsR01CA254042 · NCI · DARTMOUTH COLLEGE · PI Yina Hsing Huang, Mary Jo Turk · 2022 to 2026
$2.6M
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivityR01CA205967 · NCI · DANA-FARBER CANCER INST · PI LETAI, ANTHONY G · 2016 to 2019
$2.0M
NCATS NIH HHS UL1 TR001086NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA205967NCI NIH HHS R01 CA216265NCI NIH HHS R01 CA225028NCI NIH HHS R01 CA254042
6 · The paper itself

Abstract

This pilot study sought to evaluate the circulating levels of immune cells, particularly regulatory T-cell (Treg) subsets, before and after lung resection for non-small cell lung cancer. Twenty-five patients consented and had specimens collected. Initially, peripheral blood of 21 patients was collected for circulating immune cell studies. Two of these patients were excluded due to technical issues, leaving 19 patients for the analyses of circulating immune cells. Standard gating and high-dimensional unsupervised clustering flow cytometry analyses were performed. The blood, tumors and lymph nodes were analyzed via single-cell RNA and TCR sequencing for Treg analyses in a total of five patients (including four additional patients from the initial 21 patients). Standard gating flow cytometry revealed a transient increase in neutrophils immediately following surgery, with a variable neutrophil-lymphocyte ratio and a stable CD4-CD8 ratio. Unexpectedly, the total Treg and Treg subsets did not change with surgery with standard gating in short- or long-term follow-up. Similarly, unsupervised clustering of Tregs revealed a dominant cluster that was stable perioperatively and long-term. Two small FoxP3

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsForkhead Transcription FactorsHumansLungPilot ProjectsTumor MicroenvironmentForkhead Transcription Factorscirculating immune cellslung resectionnon-small cell lung cancerregulatory T cellssingle-cell sequencingTreg subsets

Identifiers

PMID37232845
PMCPMC10217048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.